New Findings in Breast Cancer Described from University of Alabama Birmingham [Comparison of Pd-l1 (22c3) Expression In Paired Primary and Metastatic Breast Carcinoma].

Předmět:	FLUORESCENCE in situ hybridization IMMUNE checkpoint inhibitors TUMOR-infiltrating immune cells PROGNOSIS GENE expression
Zdroj:	Women's Health Weekly; 8/9/2024, p602-602, 1p
Abstrakt:	A recent study conducted at the University of Alabama Birmingham examined the expression of PD-L1, a predictive marker for immunotherapy, in breast cancer. The study found that PD-L1 expression decreased in metastatic tumors compared to primary tumors. The researchers suggest repeating PD-L1 testing in metastatic sites and further studies to identify other predictive factors for immune checkpoint inhibitor therapy in breast cancer patients. The study highlights the need for personalized treatment approaches in breast cancer based on the specific characteristics of the tumor. [Extracted from the article]
Databáze:	Complementary Index
Externí odkaz:	Zobrazit plný text záznamu